drugset / Trial / NCT03963479
Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
RandomizedParallel-groupTriple-blindSupportive care
Summary
To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium | Other / unclassified | 50 mg | — |
| Subject | Magnesium | Other / unclassified | 100 mg | — |
| Subject | Magnesium | Other / unclassified | 200 mg | — |
| Subject | Pyridoxine | Unknown | 25 mg | — |
| Subject | Pyridoxine | Unknown | 50 mg | — |
| Subject | Pyridoxine | Unknown | 100 mg | — |